Stocks
Funds
Screener
Sectors
Watchlists
OMCL

OMCL - Omnicell Inc Stock Price, Fair Value and News

$34.40-0.70 (-1.99%)
Delayed

44/100

OMCL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

44/100

OMCL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

OMCL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OMCL Price Action

Last 7 days

-16.7%

Last 30 days

-9.0%

Last 90 days

-21.6%

Trailing 12 Months

6.6%

OMCL RSI Chart

OMCL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OMCL Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

761.69

Price/Sales (Trailing)

1.32

EV/EBITDA

14.8

Price/Free Cashflow

17.99

OMCL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

OMCL Fundamentals

OMCL Revenue

Revenue (TTM)

1.2B

Rev. Growth (Yr)

2.32%

Rev. Growth (Qtr)

1.08%

OMCL Earnings

Earnings (TTM)

2.1M

Earnings Growth (Yr)

-112.79%

Earnings Growth (Qtr)

-137.09%

OMCL Profitability

Operating Margin

83.25%

EBT Margin

0.96%

Return on Equity

0.17%

Return on Assets

0.1%

Free Cashflow Yield

5.56%

OMCL Investor Care

Buy Backs (1Y)

2.83%

Diluted EPS (TTM)

0.04

OMCL Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.1B1.1B1.2B1.2B
20241.1B1.1B1.1B1.1B
20231.3B1.2B1.2B1.1B
20221.2B1.3B1.3B1.3B
2021914.4M987.5M1.1B1.1B
2020924.2M906.4M891.3M892.2M
2019807.2M835.9M860.5M897.0M
2018746.8M754.4M771.9M787.3M
2017673.5M681.6M691.6M712.7M
2016539.3M599.5M651.0M695.9M
2015455.4M463.1M475.8M484.6M
2014395.2M406.6M425.1M440.9M
2013337.0M355.3M365.0M380.6M
2012252.5M266.9M286.8M314.0M
2011225.4M231.7M239.9M245.5M
OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
 CEO
 WEBSITEomnicell.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES3780

Omnicell Inc Frequently Asked Questions


OMCL is the stock ticker symbol of Omnicell Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Omnicell Inc is 1.56 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, OMCL's PE ratio (Price to Earnings) is 761.69 and Price to Sales (PS) ratio is 1.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OMCL PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Omnicell Inc has provided 0.027 (multiply by 100 for percentage) rate of return.